BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27362793)

  • 1. Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the brazilian group of flow cytometry (GBCFLUX).
    Sales MM; Ferreira SIACP; Ikoma MRV; Sandes AF; Beltrame MP; Bacal NS; Silva MCA; Malvezzi M; Lorand-Metze IGH; Orfao A; Yamamoto M;
    Cytometry B Clin Cytom; 2017 Sep; 92(5):398-410. PubMed ID: 27362793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
    Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
    Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders.
    Pedreira CE; Costa ES; Almeida J; Fernandez C; Quijano S; Flores J; Barrena S; Lecrevisse Q; Van Dongen JJ; Orfao A;
    Cytometry A; 2008 Dec; 73A(12):1141-50. PubMed ID: 18836994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels.
    Beltrame MP; Souto EX; Yamamoto M; Furtado FM; da Costa ES; Sandes AF; Pimenta G; Cavalcanti Júnior GB; Santos-Silva MC; Lorand-Metze I; Ikoma-Colturato MRV
    Hematol Transfus Cell Ther; 2021; 43(4):499-506. PubMed ID: 34127423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian Group of Flow Cytometry - GBCFLUX".
    Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX
    Cytometry B Clin Cytom; 2014 Apr; ():. PubMed ID: 24700616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
    Porwit A
    Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow Cytometry Applications in the Diagnosis of T/NK-Cell Lymphoproliferative Disorders.
    Jevremovic D; Olteanu H
    Cytometry B Clin Cytom; 2019 Mar; 96(2):99-115. PubMed ID: 30729667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow Cytometry.
    Gascue A; Merino J; Paiva B
    Hematol Oncol Clin North Am; 2018 Oct; 32(5):765-775. PubMed ID: 30190016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD43 and CD49d from the B-Cell Chronic Lymphoproliferative Disorders Diagnostic Panel Are Useful to Detect Erythroid Dysplasia.
    Oliveira M; Laranjeira P; Fortuna M; Bártolo R; Ribeiro A; Santos M; Cortesão E; Marques G; Sarmento-Ribeiro AB; Vitória H; Ribeiro L; Paiva A
    Cytometry B Clin Cytom; 2019 Sep; 96(5):417-425. PubMed ID: 31157955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders.
    Kotsianidis I; Nakou E; Spanoudakis E; Bouchliou I; Moustakidis E; Miltiades P; Vadikolia CM; Szydlo R; Karadimitris A; Tsatalas C
    Am J Clin Pathol; 2011 Sep; 136(3):400-8. PubMed ID: 21846915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.
    Arroz M; Came N; Lin P; Chen W; Yuan C; Lagoo A; Monreal M; de Tute R; Vergilio JA; Rawstron AC; Paiva B
    Cytometry B Clin Cytom; 2016 Jan; 90(1):31-9. PubMed ID: 25619868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.
    Costa ES; Pedreira CE; Barrena S; Lecrevisse Q; Flores J; Quijano S; Almeida J; del Carmen García-Macias M; Bottcher S; Van Dongen JJ; Orfao A
    Leukemia; 2010 Nov; 24(11):1927-33. PubMed ID: 20844562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometry in chronic lymphproliferative disorders: report of a survey on practices on behalf of CytHem].
    Mayeur-Rousse C; Bouyer S; Lesesve JF; Le Garff-Tavernier M; Baseggio L
    Ann Biol Clin (Paris); 2023 Jul; 81(3):289-303. PubMed ID: 37475170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.
    Dezorella N; Kay S; Baron S; Shapiro M; Porat Z; Deutsch V; Herishanu Y; Katz BZ
    Cytometry B Clin Cytom; 2016 May; 90(3):257-66. PubMed ID: 26082241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach to the flow cytometric detection and diagnosis of T-cell lymphoproliferative disorders.
    Meyerson HJ
    Lab Hematol; 2010 Sep; 16(3):32-52. PubMed ID: 20858587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of proceedings of the national meeting on "Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry".
    Gujral S; Subramanian PG; Patkar N; Badrinath Y; Kumar A; Tembhare P; Vazifdar A; Khodaiji S; Madkaikar M; Ghosh K; Yargop M; Dasgupta A
    Indian J Pathol Microbiol; 2008; 51(2):161-6. PubMed ID: 18603672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.
    Bárcena P; Jara-Acevedo M; Tabernero MD; López A; Sánchez ML; García-Montero AC; Muñoz-García N; Vidriales MB; Paiva A; Lecrevisse Q; Lima M; Langerak AW; Böttcher S; van Dongen JJ; Orfao A; Almeida J
    Oncotarget; 2015 Dec; 6(40):42938-51. PubMed ID: 26556869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.